(Q48718530)

14 February 2018

title

Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. (English)

1 reference

14 February 2018

main subject

cognitive dysfunction

1 reference

Yamauchi H

1

1 reference

14 February 2018

Fukuyama H

2

1 reference

14 February 2018

Nagahama Y

3

1 reference

14 February 2018

Katsumi Y

4

1 reference

14 February 2018

Dong Y

5

1 reference

14 February 2018

Konishi J

6

1 reference

14 February 2018

Kimura J

7

1 reference

14 February 2018

publication date

1 May 1997

1 reference

14 February 2018

published in

Annals of Neurology

1 reference

14 February 2018

volume

41

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

606-614

1 reference

14 February 2018

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410509

Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410509

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410509

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410509

Frontal lobe function in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410509

Pneumoencephalography of progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410509

21 January 2018

Identifiers

DOI

10.1002/ANA.410410509

1 reference

14 February 2018

PubMed ID

9153522

1 reference

14 February 2018